Household net worth linked to hormonal therapy adherence among patients with breast cancer
the ONA take:
According to a recent study published in the Journal of Clinical Oncology, researchers from the Herbert Irving Comprehensive Cancer Center at New York-Presbyterian/Columbia University Medical Center in New York City have found that household net worth is a major factor in adherence to hormonal therapy among patients with breast cancer that is often overlooked, possibly explaining racial disparities in quality of care.
In order to study the effect of household net worth on quality of care in patients with breast cancer, the researchers analyzed financial and prescription data on 2,437 women aged 50 years and older with early-stage breast cancer who had been prescribed aromatase inhibitors, such as anastrozole or letrozole, between 2007 and 2011. Results showed that income and net worth were directly associated with medication adherence.
The authors note that the findings suggest that healthcare professionals, health insurers, and policy makers need to consider this economic variable so that patients with breast cancer can receive potentially life-saving treatment.
Healthcare providers must engage their patients in a conversation about whether they will be able to afford their medications, so that a solution can be determined to reduce non-adherence and improve outcomes.
Household net worth is a major factor in adherence to hormonal therapy among patients with breast cancer.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
- Clinical Trials May Benefit Oncology Patients
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|